highly significantp < 0.001
Glibenclamide (10 mg/kg) exhibited highly significant ( p < 0.001) hypoglycemic effects throughout the study period.
Glibenclamide (10 mg/kg) exhibited highly significant ( p < 0.001) hypoglycemic effects throughout the study period.